Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

review

  • Open Access
    Biospecimen Digital Twins: Moving from a “High Quality” to a “Fit-for-Purpose” Concept in the Era of Omics Sciences
    UMBERTO NANNI, PATRIZIA FERRONI, SILVIA RIONDINO, ANTONELLA SPILA, MARIA GIOVANNA VALENTE, GIROLAMO DEL MONTE, MARIO ROSELLI and FIORELLA GUADAGNI
    Cancer Genomics & Proteomics May 2023, 20 (3) 211-221; DOI: https://doi.org/10.21873/cgp.20376
  • Open Access
    Breast Cancer: Circular RNAs Mediating Efficacy in Preclinical In Vivo Models
    ULRICH H. WEIDLE, HUNG-EN HSIA and ULRICH BRINKMANN
    Cancer Genomics & Proteomics May 2023, 20 (3) 222-238; DOI: https://doi.org/10.21873/cgp.20377
  • Open Access
    Triple-negative Breast Cancer: Identification of circRNAs With Efficacy in Preclinical In Vivo Models
    ULRICH H. WEIDLE and FABIAN BIRZELE
    Cancer Genomics & Proteomics March 2023, 20 (2) 117-131; DOI: https://doi.org/10.21873/cgp.20368
  • Open Access
    Up-regulated Circular RNAs in Colorectal Cancer: New Entities for Therapy and Tools for Identification of Therapeutic Targets
    ULRICH H. WEIDLE and ADAM NOPORA
    Cancer Genomics & Proteomics March 2023, 20 (2) 132-153; DOI: https://doi.org/10.21873/cgp.20369
  • Open Access
    Neoplasia-associated Chromosome Translocations Resulting in Gene Truncation
    IOANNIS PANAGOPOULOS and SVERRE HEIM
    Cancer Genomics & Proteomics November 2022, 19 (6) 647-672; DOI: https://doi.org/10.21873/cgp.20349
  • Open Access
    Long Non-coding RNAs With In Vitro and In Vivo Efficacy in Preclinical Models of Esophageal Squamous Cell Carcinoma Which Act by a Non-microRNA Sponging Mechanism
    ULRICH H. WEIDLE and FABIAN BIRZELE
    Cancer Genomics & Proteomics July 2022, 19 (4) 372-389; DOI: https://doi.org/10.21873/cgp.20327
  • Open Access
    Circular RNAs With Efficacy in Preclinical In Vitro and In Vivo Models of Esophageal Squamous Cell Carcinoma
    ULRICH H. WEIDLE, TATJANA SELA, ULRICH BRINKMANN and JENS NIEWOEHNER
    Cancer Genomics & Proteomics May 2022, 19 (3) 283-298; DOI: https://doi.org/10.21873/cgp.20320
  • You have access
    MicroRNAs and Corresponding Targets in Esophageal Cancer as Shown In Vitro and In Vivo in Preclinical Models
    ULRICH H. WEIDLE and ADAM NOPORA
    Cancer Genomics & Proteomics March 2022, 19 (2) 113-129; DOI: https://doi.org/10.21873/cgp.20308
  • You have access
    The Application of Bayesian Methods in Cancer Prognosis and Prediction
    JIADONG CHU, NA SUN, WEI HU, XUANLI CHEN, NENGJUN YI and YUEPING SHEN
    Cancer Genomics & Proteomics January 2022, 19 (1) 1-11; DOI: https://doi.org/10.21873/cgp.20298
  • You have access
    MicroRNAs Involved in Small-cell Lung Cancer as Possible Agents for Treatment and Identification of New Targets
    ULRICH H. WEIDLE and ADAM NOPORA
    Cancer Genomics & Proteomics September 2021, 18 (5) 591-603; DOI: https://doi.org/10.21873/cgp.20283

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Cancer & Genome Proteomics

© 2023 Cancer Genomics & Proteomics

Powered by HighWire